<DOC>
	<DOCNO>NCT00351884</DOCNO>
	<brief_summary>Vildagliptin oral anti-diabetic agent . This 24-week study ass efficacy HbA1c 100 mg vildagliptin daily compare placebo add-on metformin patient type 2 diabetes inadequately control metformin .</brief_summary>
	<brief_title>Efficacy Vildagliptin 100 MG Compared Placebo Add-on Metformin Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vildagliptin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Patients metformin least three month stable dose least 1500 mg daily minimum 4 week prior visit 1 Body mass index range 2240 Blood glucose criterion must meet Pregnancy lactation History type 1 diabetes Evidence significant diabetic complication Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>vildagliptin</keyword>
	<keyword>Hemoglobin A1c</keyword>
</DOC>